ISTA PHARMACEUTICALS INC Direct Operating Cost, Royalty Expense (Deprecated 2018-01-31)
ISTA PHARMACEUTICALS INC reported Direct Operating Cost, Royalty Expense (Deprecated 2018-01-31) of $9.31 million for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DirectOperatingCostRoyaltyExpense · last filed 2012-05-04
- ISTA PHARMACEUTICALS INC direct operating cost, royalty expense (deprecated 2018-01-31) for the quarter ending 2012-03-31 was $9.31M.
| Period end | Direct Operating Cost, Royalty Expense (Deprecated 2018-01-31) 3 month |
|---|---|
| 2012-03-31 | $9.31M 10-Q · filed 2012-05-04 |